Pharmacological and nutraceutical treatments for borderline personality disorder

被引：0

作者：

Gerolymos, Cyril ^{[1
]}

Boyer, Laurent ^{[1
,4
]}

Masson, Marc ^{[2
,3
]}

Fond, Guillaume ^{[4
]}

机构：

[1] Aix Marseille Univ, CeRESS, AP HM, 27 Blvd Jean Moulin, F-13005 Marseille, France

[2] GHU Paris Psychiat & Neurosci, Serv SHU, 1 rue Cabanis, F-75014 Paris, France

[3] Amer Hosp Paris, Dept Cardiol, 63 Blvd Victor Hugo, F-92200 Neuilly Sur Seine, France

[4] Fdn Fondamental, 27 Blvd Jean Moulin, F-13005 Creteil, France

来源：

ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE | 2024年 / 50卷 / 05期

关键词：

Mental health; Psychiatric disorders; Depressive disorders; Borderline personality disorders; Emotional dysregulation; Antidepressants; Antipsychotics; DIALECTICAL BEHAVIOR-THERAPY; DOUBLE-BLIND; TOPIRAMATE TREATMENT; OLANZAPINE; AGGRESSION; WOMEN; HALOPERIDOL; FLUOXETINE; EFFICACY; PHARMACOTHERAPY;

D O I：

10.1016/j.encep.2024.04.001

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：479 / 482

页数：4

共 27 条

[1] Comparison of Low and Moderate Dosages of Extended-Release Quetiapine in Borderline Personality Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial [J].

Black, Donald W. ;

Zanarini, Mary C. ;

Romine, Ann ;

Shaw, Martha ;

Allen, Jeff ;

Schulz, S. Charles .

AMERICAN JOURNAL OF PSYCHIATRY, 2014, 171 (11) :1174-1182

[2] Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial [J].

Bozzatello, Paola ;

Rocca, Paola ;

Uscinska, Maria ;

Bellino, Silvio .

CNS DRUGS, 2017, 31 (09) :809-819

[3]

Coccaro EF, 1997, ARCH GEN PSYCHIAT, V54, P1081

[4]

CORNELIUS JR, 1993, AM J PSYCHIAT, V150, P1843

[5]

COWDRY RW, 1988, ARCH GEN PSYCHIAT, V45, P111

[6] How can we improve the care of patients with schizophrenia in the real-world? A population-based cohort study of 456,003 patients [J].

Fond, Guillaume ;

Falissard, Bruno ;

Nuss, Philippe ;

Collin, Cedric ;

Duret, Stephanie ;

Rabbani, Marc ;

De Chefdebien, Isabelle ;

Tonelli, Isabelle ;

Llorca, Pierre Michel ;

Boyer, Laurent .

MOLECULAR PSYCHIATRY, 2023, 28 (12) :5328-5336

[7] Divalproex in the treatment of impulsive aggression: Efficacy in Cluster B personality disorders [J].

Hollander, E ;

Tracy, KA ;

Swann, AC ;

Coccaro, EF ;

McElroy, SL ;

Wozniak, P ;

Sommerville, KW ;

Nemeroff, CB .

NEUROPSYCHOPHARMACOLOGY, 2003, 28 (06) :1186-1197

[8] Borderline personality disorder: a comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies [J].

Leichsenring, Falk ;

Fonagy, Peter ;

Heim, Nikolas ;

Kernberg, Otto F. ;

Leweke, Frank ;

Luyten, Patrick ;

Salzer, Simone ;

Spitzer, Carsten ;

Steinert, Christiane .

WORLD PSYCHIATRY, 2024, 23 (01) :4-25

[9] Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: A double-blind, placebo-controlled pilot study [J].

Linehan, Marsha M. ;

McDavid, Joshua D. ;

Brown, Milton Z. ;

Sayrs, Jennifer H. R. ;

Gallop, Robert J. .

JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (06) :999-1005

[10] Topiramate treatment for women with borderline personality disorder - A double-blind, placebo-controlled study [J].

Loew, TH ;

Nickel, MK ;

Muehlbacher, M ;

Kaplan, P ;

Nickel, C ;

Kettler, C ;

Fartacek, R ;

Lahmann, C ;

Buschmann, W ;

Tritt, K ;

Bachler, E ;

Mitterlehner, F ;

Gil, FP ;

Leiberich, P ;

Rother, WK ;

Egger, C .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (01) :61-66

← 1 2 3 →